Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
Authors
Keywords
-
Journal
FEBS LETTERS
Volume 588, Issue 2, Pages 288-297
Publisher
Wiley
Online
2013-12-02
DOI
10.1016/j.febslet.2013.11.030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preassociation of IL-15 with IL-15R -IgG1-Fc Enhances Its Activity on Proliferation of NK and CD8+/CD44high T Cells and Its Antitumor Action
- (2014) S. Dubois et al. JOURNAL OF IMMUNOLOGY
- Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging
- (2013) L Liebsch et al. BRITISH JOURNAL OF CANCER
- Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo
- (2013) Denis Cochonneau et al. CANCER LETTERS
- Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
- (2013) Y. Liu et al. CLINICAL CANCER RESEARCH
- Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency
- (2013) Marie Vincent et al. INTERNATIONAL JOURNAL OF CANCER
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- In silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors
- (2013) Mahiuddin Ahmed et al. PLoS One
- Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells
- (2013) Y.-J. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanocarrier-Mediated Targeting of Tumor and Tumor Vascular Cells Improves Uptake and Penetration of Drugs into Neuroblastoma
- (2013) Fabio Pastorino et al. Frontiers in Oncology
- Immunosuppressive Microenvironment in Neuroblastoma
- (2013) Vito Pistoia et al. Frontiers in Oncology
- Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
- (2012) Mark R. Albertini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Trifunctional Bispecific Antibodies Induce Tumor-Specific T Cells and Elicit a Vaccination Effect
- (2012) Nina Eissler et al. CANCER RESEARCH
- Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3
- (2012) Hidenobu Shibuya et al. CANCER SCIENCE
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Interleukin 2 in Cancer Therapy
- (2012) G. K. Antony et al. CURRENT MEDICINAL CHEMISTRY
- The ganglioside GD2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD3 synthase
- (2012) Aurélie Cazet et al. GLYCOBIOLOGY
- An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma
- (2012) Min Shen International Journal of Nanomedicine
- The Immunologic Functions of the Neonatal Fc Receptor for IgG
- (2012) Timo Rath et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
- (2012) Venkata Lokesh Battula et al. JOURNAL OF CLINICAL INVESTIGATION
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
- (2012) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model
- (2012) Peter Ruf et al. Journal of Translational Medicine
- Effect of tumor gangliosides on tyrosine phosphorylation of p125FAK in platelet adhesion to collagen
- (2012) YI-XIN CHEN et al. ONCOLOGY REPORTS
- Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets
- (2012) Maxim Yankelevich et al. PEDIATRIC BLOOD & CANCER
- Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
- (2012) Amanda Tivnan et al. PLoS One
- Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
- (2012) Nai-Kong V. Cheung et al. OncoImmunology
- Expression of GD2 and GD3 Gangliosides in Human Embryonic Neural Stem Cells
- (2011) Makoto Yanagisawa et al. ASN Neuro
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
- (2011) Ruth Esser et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Successful Multifold Dose Escalation of Anti-GD2Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study
- (2011) Brian H. Kushner et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of Peripheral-Blood Granulocytes Is Strongly Correlated With Patient Outcome After Immunotherapy With Anti-GD2 Monoclonal Antibody and Granulocyte-Macrophage Colony-Stimulating Factor
- (2011) Irene Y. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
- (2011) Daniela Di Paolo et al. MOLECULAR THERAPY
- Selective Therapeutic Targeting of the Anaplastic Lymphoma Kinase With Liposomal siRNA Induces Apoptosis and Inhibits Angiogenesis in Neuroblastoma
- (2011) Daniela Di Paolo et al. MOLECULAR THERAPY
- Targeted Delivery to Neuroblastoma of Novel siRNA-anti-GD2-liposomes Prepared by Dual Asymmetric Centrifugation and Sterol-Based Post-Insertion Method
- (2011) Joanna E. Adrian et al. PHARMACEUTICAL RESEARCH
- A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
- (2011) Nidia Alvarez-Rueda et al. PLoS One
- Interleukin-15 biology and its therapeutic implications in cancer
- (2011) Jason C. Steel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Anti-Neuroblastoma Activity of Gold Nanorods Bound with GD2 Monoclonal Antibody under Near-Infrared Laser Irradiation
- (2011) Ching-An Peng et al. Cancers
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells
- (2010) Hye Jin Jin et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Anti-GD3 Chimeric sFv-CD28/T-Cell Receptor Designer T Cells for Treatment of Metastatic Melanoma and Other Neuroectodermal Tumors
- (2010) A. S. Y. Lo et al. CLINICAL CANCER RESEARCH
- Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
- (2010) F. Navid et al. CURRENT CANCER DRUG TARGETS
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging
- (2010) Kelly Davis Orcutt et al. NUCLEAR MEDICINE AND BIOLOGY
- Anti-GD2 with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia
- (2010) Linda S. Sorkin et al. PAIN
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
- (2009) E. Yvon et al. CLINICAL CANCER RESEARCH
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Reducing Epitope Spread during Affinity Maturation of an Anti-Ganglioside GD2 Antibody
- (2009) J. Hu et al. JOURNAL OF IMMUNOLOGY
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
- (2009) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- In vitrophotothermal destruction of neuroblastoma cells using carbon nanotubes conjugated with GD2 monoclonal antibody
- (2009) Chung-Hao Wang et al. NANOTECHNOLOGY
- Interleukin-15/Interleukin-15R Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells
- (2008) M. Epardaud et al. CANCER RESEARCH
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group
- (2008) Andrew L. Gilman et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search